Company Active LTD

Company profile

BDD Pharma Ltd

UK company SC212868, incorporated on 15 November 2000.

BDD Clinical Trials

Cinical Trials with BDD at the Glasgow Royal Infirmary.

Company number

SC212868

Incorporated

15 Nov 2000

Companies House status

Active

Company identity

Founded / incorporated

15 November 2000

Company number SC212868

Verify at Companies House

Legal name

BDD PHARMA LTD

Company type

Private Limited Company

Region

Unknown

Registered address

BIO IMAGING UNIT, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY

84 CASTLE STREET

GLASGOW

SCOTLAND

G4 0SF

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller

Company Active LTD

BDD Pharma Ltd

CRN SC212868

Direct and ultimate controller Active LTD

Bio-Images Drug Delivery Ltd

CRN SC383233

Latest accounts

Financial period: 1 Dec 2023 to 30 Nov 2024

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

Company events

Reference milestones and recent Companies House filing stream events.

6 events

29 Nov

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Aug

2026

Accounts due

Accounts Due

Next accounts due date

03 Aug

2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUzNjY5MzgwMWFkaXF6a2N4

Published 03 Aug 2026 13:40

15 Nov

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Nov

2024

Accounts filed

Accounts

Last accounts made up date

15 Nov

2000

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2011

Funded years

2011, 2013

Age at first award

10 years

Projects

2013 EU-Funded Lead participant

OligoG

1 Jun 2013 to 30 Nov 2014

Awarded

£249,867

Total cost £499,733

Awaiting Public Project Summary

2011 Knowledge Transfer Partnership

University of Strathclyde And Bio-Images Research Limited

1 May 2011 to 31 May 2014

Awarded

Unknown

To diversify a contract research provision and establish a new drug delivery division that will provide opportunities for high business growth.

Product types

EU-Funded Knowledge Transfer Partnership